About
Technology
Issues
FAQ
Links
Official Page
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.